These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 11245477)

  • 1. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
    Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
    Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.
    Jimi E; Akiyama S; Tsurukai T; Okahashi N; Kobayashi K; Udagawa N; Nishihara T; Takahashi N; Suda T
    J Immunol; 1999 Jul; 163(1):434-42. PubMed ID: 10384146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
    Lee SK; Lorenzo JA
    Endocrinology; 1999 Aug; 140(8):3552-61. PubMed ID: 10433211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mouse mammary tumor cell line, MMT060562, produces prostaglandin E2 and leukemia inhibitory factor and supports osteoclast formation in vitro via a stromal cell-dependent pathway.
    Akatsu T; Ono K; Katayama Y; Tamura T; Nishikawa M; Kugai N; Yamamoto M; Nagata N
    J Bone Miner Res; 1998 Mar; 13(3):400-8. PubMed ID: 9525340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant melanoma and bone resorption.
    Lau YS; Sabokbar A; Giele H; Cerundolo V; Hofstetter W; Athanasou NA
    Br J Cancer; 2006 May; 94(10):1496-503. PubMed ID: 16641914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.
    Yasuda H; Shima N; Nakagawa N; Yamaguchi K; Kinosaki M; Mochizuki S; Tomoyasu A; Yano K; Goto M; Murakami A; Tsuda E; Morinaga T; Higashio K; Udagawa N; Takahashi N; Suda T
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3597-602. PubMed ID: 9520411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.
    Kotake S; Udagawa N; Takahashi N; Matsuzaki K; Itoh K; Ishiyama S; Saito S; Inoue K; Kamatani N; Gillespie MT; Martin TJ; Suda T
    J Clin Invest; 1999 May; 103(9):1345-52. PubMed ID: 10225978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.
    Abu-Amer Y; Ross FP; Edwards J; Teitelbaum SL
    J Clin Invest; 1997 Sep; 100(6):1557-65. PubMed ID: 9294124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells.
    Takai H; Kanematsu M; Yano K; Tsuda E; Higashio K; Ikeda K; Watanabe K; Yamada Y
    J Biol Chem; 1998 Oct; 273(42):27091-6. PubMed ID: 9765225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone.
    Tsukii K; Shima N; Mochizuki S; Yamaguchi K; Kinosaki M; Yano K; Shibata O; Udagawa N; Yasuda H; Suda T; Higashio K
    Biochem Biophys Res Commun; 1998 May; 246(2):337-41. PubMed ID: 9610359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.
    Burgess TL; Qian Y; Kaufman S; Ring BD; Van G; Capparelli C; Kelley M; Hsu H; Boyle WJ; Dunstan CR; Hu S; Lacey DL
    J Cell Biol; 1999 May; 145(3):527-38. PubMed ID: 10225954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold clusters prevent breast cancer bone metastasis by suppressing tumor-induced osteoclastogenesis.
    Zhang Z; Yao Y; Yuan Q; Lu C; Zhang X; Yuan J; Hou K; Zhang C; Du Z; Gao X; Chen X
    Theranostics; 2020; 10(9):4042-4055. PubMed ID: 32226538
    [No Abstract]   [Full Text] [Related]  

  • 13. Sulforaphane inhibits osteoclastogenesis by inhibiting nuclear factor-kappaB.
    Kim SJ; Kang SY; Shin HH; Choi HS
    Mol Cells; 2005 Dec; 20(3):364-70. PubMed ID: 16404151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evidence for stimulation of bone resorption by an EP4 receptor agonist and basic fibroblast growth factor: Implications for their efficacy as bone anabolic agents.
    Downey ME; Holliday LS; Aguirre JI; Wronski TJ
    Bone; 2009 Feb; 44(2):266-74. PubMed ID: 19013265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone.
    Zhang J; Dai J; Qi Y; Lin DL; Smith P; Strayhorn C; Mizokami A; Fu Z; Westman J; Keller ET
    J Clin Invest; 2001 May; 107(10):1235-44. PubMed ID: 11375413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of triiodothyronine with 1alpha,25-dihydroxyvitamin D3 on interleukin-6-dependent osteoclast-like cell formation in mouse bone marrow cell cultures.
    Schiller C; Gruber R; Ho GM; Redlich K; Gober HJ; Katzgraber F; Willheim M; Hoffmann O; Pietschmann P; Peterlik M
    Bone; 1998 Apr; 22(4):341-6. PubMed ID: 9556133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma.
    Qiang YW; Chen Y; Stephens O; Brown N; Chen B; Epstein J; Barlogie B; Shaughnessy JD
    Blood; 2008 Jul; 112(1):196-207. PubMed ID: 18305214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis.
    Nakajima K; Kho DH; Yanagawa T; Harazono Y; Hogan V; Chen W; Ali-Fehmi R; Mehra R; Raz A
    Cancer Res; 2016 Mar; 76(6):1391-402. PubMed ID: 26837763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of prostaglandin endoperoxide H synthase-2 in osteoclast formation induced by parathyroid hormone.
    Tokushima T; Sato T; Morita I; Murota S
    Adv Exp Med Biol; 1997; 433():307-9. PubMed ID: 9561158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse mammary carcinoma cell line (BALB/c-MC) stimulates osteoclast formation from mouse bone marrow cells through cell-to-cell contact.
    Ono K; Akatsu T; Murakami T; Wada S; Nishikawa M; Kugai N; Yamamoto M; Matsuura N; Nagata N
    Bone; 1998 Jul; 23(1):27-32. PubMed ID: 9662127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.